FTC sends warning letters to three companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol, or CBD, a chemical compound derived from the cannabis plant. Agency didn’t identify the companies.
- FTC in a statement says it is warning the companies “that it is illegal to advertise that a product can prevent, treat, or cure human disease without competent and reliable scientific evidence to support such claims”
- Claims made include pain relief better than prescription opioids and treatment of ailments including cancer, Alzheimer’s disease, depression, arthritis, multiple sclerosis
- FTC, which didn’t release the letters, urges the companies to ensure ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.